Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| S13A3 | Q8WWT9 | Na(+)/dicarboxylate cotransporter 3 (NaDC-3) (hNaDC3) (Na(+)-coupled carboxylate transporter 3) (NaC3) (Sodium-dependent high-affinity dicarboxylate transporter 2) (Solute carrier family 13 member 3) (SLC13A3) | Disease related genesMetabolic proteinsPotential drug targets | 11 | Fusion and delivery mediation | 12 | 0.72 | |||
| STML3 | Q8TAV4 | Stomatin-like protein 3 (SLP-3) | Predicted membrane proteinsTransporters | 1 | Fusion and delivery mediation | 12 | 0.72 | |||
| SUSD2 | Q9UGT4 | Sushi domain-containing protein 2 | Predicted membrane proteins | 1 | Other mediation | 12 | 0.72 | |||
| TM63B | Q5T3F8 | Mechanosensitive cation channel TMEM63B (Transmembrane protein 63B) (hTMEM63B) | Predicted membrane proteinsTransporters | 11 | Fusion and delivery mediationMetabolism mediation | 12 | 0.72 | |||
| CD248 | Q9HCU0 | Endosialin (Tumor endothelial marker 1) (CD antigen CD248) | CD markersPredicted membrane proteins | 1 | Colorectal cancerKaposi sarcomaMelanoma | Clinical-translation mediationFusion and delivery mediation | 11 | 0.72 | ||
| GLPC | P04921 | Glycophorin-C (Glycoconnectin) (Glycophorin-D) (GPD) (Glycoprotein beta) (PAS-2') (Sialoglycoprotein D) (CD antigen CD236) | Blood group antigen proteinsCD markersPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediation | 11 | 0.72 | |||
| MYCT | Q96QE2 | Proton myo-inositol cotransporter (H(+)-myo-inositol cotransporter) (Hmit) (H(+)-myo-inositol symporter) (Solute carrier family 2 member 13) | Metabolic proteinsPredicted membrane proteinsTransporters | 12 | Fusion and delivery mediation | 11 | 0.72 | |||
| NLGN1 | Q8N2Q7 | Neuroligin-1 | Disease related genesHuman disease related genesPotential drug targets | 1 | Adhesion and uptake mediationFusion and delivery mediation | 11 | 0.72 | |||
| S27A1 | Q6PCB7 | Long-chain fatty acid transport protein 1 (Arachidonate--CoA ligase) (EC 6.2.1.15) (Fatty acid transport protein 1) (FATP-1) (Long-chain-fatty-acid--CoA ligase) (EC 6.2.1.3) (Solute carrier family 27 member 1) (Very long-chain acyl-CoA synthetase) (EC 6.2.1.-) | 1 | Fusion and delivery mediationMetabolism mediation | 11 | 0.72 | ||||
| CD63 | P08962 | CD63 antigen (Granulophysin) (Lysosomal-associated membrane protein 3) (LAMP-3) (Lysosome integral membrane protein 1) (Limp1) (Melanoma-associated antigen ME491) (OMA81H) (Ocular melanoma-associated antigen) (Tetraspanin-30) (Tspan-30) (CD antigen CD63) | CD markersPlasma proteinsPredicted membrane proteins | 4 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 765 | 0.63 | |||
| CTL1 | Q8WWI5 | Choline transporter-like protein 1 (CDw92) (Solute carrier family 44 member 1) (CD antigen CD92) | CD markersDisease related genesMetabolic proteins | 9 | Fusion and delivery mediationMetabolism mediation | 31 | 0.63 | |||
| BCAM | P50895 | Basal cell adhesion molecule (Auberger B antigen) (B-CAM cell surface glycoprotein) (F8/G253 antigen) (Lutheran antigen) (Lutheran blood group glycoprotein) (CD antigen CD239) | Blood group antigen proteinsCD markersPlasma proteins | 1 | Adhesion and uptake mediationFusion and delivery mediation | 27 | 0.63 | |||
| SPP2A | Q8TCT8 | Signal peptide peptidase-like 2A (SPP-like 2A) (SPPL2a) (EC 3.4.23.-) (Intramembrane protease 3) (IMP-3) (Presenilin-like protein 2) | Disease related genesEnzymesHuman disease related genes | 9 | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 27 | 0.63 | |||
| EPHA4 | P54764 | Ephrin type-A receptor 4 (EC 2.7.10.1) (EPH-like kinase 8) (EK8) (hEK8) (Tyrosine-protein kinase TYRO1) (Tyrosine-protein kinase receptor SEK) | Cancer-related genesEnzymesPlasma proteins | 1 | Solid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 24 | 0.63 | ||
| CELR2 | Q9HCU4 | Cadherin EGF LAG seven-pass G-type receptor 2 (Cadherin family member 10) (Epidermal growth factor-like protein 2) (EGF-like protein 2) (Flamingo homolog 3) (Multiple epidermal growth factor-like domains protein 3) (Multiple EGF-like domains protein 3) | Essential proteinsG-protein coupled receptorsPredicted membrane proteins | 7 | Adhesion and uptake mediationReceptor-signaling mediation | 22 | 0.63 | |||
| APLP2 | Q06481 | Amyloid beta precursor like protein 2 (APPH) (Amyloid beta (A4) precursor-like protein 2) (Amyloid protein homolog) (Amyloid-like protein 2) (APLP-2) (CDEI box-binding protein) (CDEBP) (Sperm membrane protein YWK-II) | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Fusion and delivery mediationImmune mediationMetabolism mediation | 21 | 0.63 | |||
| LHPL2 | Q6ZUX7 | LHFPL tetraspan subfamily member 2 protein (Lipoma HMGIC fusion partner-like 2 protein) | Predicted membrane proteins | 4 | Fusion and delivery mediation | 10 | 0.63 | |||
| OCLN | Q16625 | Occludin | Disease related genesHuman disease related genesPotential drug targets | 4 | Fusion and delivery mediationReceptor-signaling mediation | 10 | 0.63 | |||
| SGCE | O43556 | Epsilon-sarcoglycan (Epsilon-SG) | 1 | Adhesion and uptake mediation | 10 | 0.63 | ||||
| TRPV2 | Q9Y5S1 | Transient receptor potential cation channel subfamily V member 2 (TrpV2) (Osm-9-like TRP channel 2) (OTRPC2) (Vanilloid receptor-like protein 1) (VRL-1) | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 6 | Fusion and delivery mediationMetabolism mediation | 10 | 0.63 | |||
| CLC5A | Q9NY25 | C-type lectin domain family 5 member A (C-type lectin superfamily member 5) (Myeloid DAP12-associating lectin 1) (MDL-1) | 1 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 9 | 0.63 | ||||
| CR1 | P17927 | Complement receptor type 1 (C3b/C4b receptor) (CD antigen CD35) | Blood group antigen proteinsCD markersPlasma proteins | 1 | Retinopathy | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 9 | 0.63 | ||
| EDNRA | P25101 | Endothelin-1 receptor (Endothelin receptor type A) (ET-A) (ETA-R) (hET-AR) | Disease related genesFDA approved drug targetsG-protein coupled receptors | 7 | Anxiety disorderCardiac arrhythmiaCardiovascular disease | Clinical-translation mediationFusion and delivery mediationImmune mediation | 9 | 0.63 | ||
| FZD1 | Q9UP38 | Frizzled-1 (Fz-1) (hFz1) (FzE1) | Cancer-related genesG-protein coupled receptorsPlasma proteins | 7 | Adhesion and uptake mediationReceptor-signaling mediation | 9 | 0.63 | |||
| ICAM1 | P05362 | Intercellular adhesion molecule 1 (ICAM-1) (Major group rhinovirus receptor) (CD antigen CD54) | Cancer-related genesCandidate cardiovascular disease genesCD markers | 1 | Conjunctiva disorderCrohn diseaseIndeterminate colitis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 9 | 0.63 |